Skip to main content

Table 6 CMR findings GPA

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

 

Controls (n = 20)

Patients (n = 15)

p

LV-EF (%)

65 ± 4

68 ± 7

0.24

LV-EDV (ml)

109 ± 27

118 ± 28

0.57

LV-ESV (ml)

39 ± 13

39 ± 14

0.91

LV-SV

71 ± 15

80 ± 20

0.19

LV-EDD

45 ± 5

47 ± 4

0.36

LA (cm2)

20 ± 3

20 ± 3

0.71

IVS (mm)

10 ± 2

11 ± 2

0.11

PA (mm)

24 ± 4

24 ± 4

0.78

LV mass (g)

85 ± 20

92 ± 25

0.57

LGE per patient

-

7 (47%)

 

epicardial

-

3 (20%)

 

intramural

-

4 (27%)

 

transmural

-

-

 

subendocardial

-

-

 

% LV mass

-

6.3 ± 4

 

Native T1 (ms)

952 (923–960)

1002 (972–1023)

<0.001

Post-contrast T1 (ms)

524 (500–529)

490 (477–551)

0.16

ECV (%)

24.5 (23–25)

27 (26–28)

<0.001

T2 (ms)

49 (48–51)

53 (51–54)

<0.001

  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume